Free Trial

Novacyt (NCYT) Competitors

Novacyt logo
GBX 38.50 -1.95 (-4.82%)
As of 05/22/2025 12:42 PM Eastern

NCYT vs. IUG, CREO, POLX, IHC, AVO, RUA, MHC, SUN, BELL, and DEMG

Should you be buying Novacyt stock or one of its competitors? The main competitors of Novacyt include Intelligent Ultrasound Group (IUG), Creo Medical Group (CREO), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), MyHealthChecked (MHC), Surgical Innovations Group (SUN), Belluscura (BELL), and Deltex Medical Group (DEMG). These companies are all part of the "medical devices" industry.

Novacyt vs.

Novacyt (LON:NCYT) and Intelligent Ultrasound Group (LON:IUG) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, community ranking, risk, institutional ownership, earnings, dividends and analyst recommendations.

Intelligent Ultrasound Group has lower revenue, but higher earnings than Novacyt. Novacyt is trading at a lower price-to-earnings ratio than Intelligent Ultrasound Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novacyt£18.12M1.47-£36.80M-£54.44-0.71
Intelligent Ultrasound Group£6.57M0.00-£2.27M-£0.68N/A

Novacyt received 36 more outperform votes than Intelligent Ultrasound Group when rated by MarketBeat users.

CompanyUnderperformOutperform
NovacytOutperform Votes
36
58.06%
Underperform Votes
26
41.94%
Intelligent Ultrasound GroupN/AN/A

0.1% of Novacyt shares are owned by institutional investors. Comparatively, 75.5% of Intelligent Ultrasound Group shares are owned by institutional investors. 3.1% of Novacyt shares are owned by insiders. Comparatively, 12.8% of Intelligent Ultrasound Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Novacyt has a beta of -1.86, indicating that its stock price is 286% less volatile than the S&P 500. Comparatively, Intelligent Ultrasound Group has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500.

Intelligent Ultrasound Group has a net margin of -34.56% compared to Novacyt's net margin of -203.06%. Intelligent Ultrasound Group's return on equity of -37.71% beat Novacyt's return on equity.

Company Net Margins Return on Equity Return on Assets
Novacyt-203.06% -47.73% -27.98%
Intelligent Ultrasound Group -34.56%-37.71%-13.51%

In the previous week, Novacyt's average media sentiment score of 0.00 equaled Intelligent Ultrasound Group'saverage media sentiment score.

Company Overall Sentiment
Novacyt Neutral
Intelligent Ultrasound Group Neutral

Summary

Intelligent Ultrasound Group beats Novacyt on 8 of the 11 factors compared between the two stocks.

Get Novacyt News Delivered to You Automatically

Sign up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NCYT vs. The Competition

MetricNovacytMedical Devices IndustryMedical SectorLON Exchange
Market Cap£26.60M£3.32B£5.33B£2.64B
Dividend YieldN/A2.44%5.21%5.05%
P/E Ratio-0.7170.1626.80134.69
Price / Sales1.47106.29397.78224,245.30
Price / Cash0.5815.9938.2528.03
Price / Book0.393.596.773.80
Net Income-£36.80M£126.02M£3.23B£5.88B
7 Day Performance-0.52%3.65%0.48%0.43%
1 Month Performance-3.91%6.71%9.13%21.47%
1 Year Performance-43.40%-3.33%18.58%129.56%

Novacyt Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NCYT
Novacyt
N/AGBX 38.50
-4.8%
N/A-36.9%£26.60M£18.12M-0.71120
IUG
Intelligent Ultrasound Group
N/AN/AN/AN/A£42.76M£6.57M-18.9165
CREO
Creo Medical Group
N/AGBX 10.17
-0.8%
N/A-66.3%£41.12M£33.87M-1.61279Earnings Report
POLX
Polarean Imaging
N/AGBX 1.23
+2.5%
N/A-19.0%£18.05M£5.21M-0.3228Gap Up
High Trading Volume
IHC
Inspiration Healthcare Group
N/AGBX 17.50
-2.8%
N/A+23.5%£15.16M£42.87M-1.20224
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
RUA
RUA Life Sciences
N/AGBX 11.53
-3.9%
N/A-14.4%£7.15M£4.05M-2.6948Positive News
Gap Down
MHC
MyHealthChecked
N/AGBX 13
+4.0%
N/A+11.1%£6.77M£9.43M-6.4816Gap Up
SUN
Surgical Innovations Group
N/AGBX 0.68
+3.8%
N/A+34.0%£6.30M£12.54M-21.1180Gap Up
BELL
Belluscura
N/AGBX 1
-12.5%
N/A-93.9%£2.52M£2.87M-0.1124High Trading Volume
DEMG
Deltex Medical Group
N/AN/AN/AN/A£187,000.00£1.76M-0.1537Gap Up
High Trading Volume

Related Companies and Tools


This page (LON:NCYT) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners